Ping Zhao is currently the Scientific Lead of PBPK (physiologically-based pharmacokinetic modeling) Program, Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Sciences, Food and Drug Administration (FDA). He obtained his BS in Pharmacy from Beijing Medical University in China in 1994, and his PhD in Pharmaceutics from University of Washington in Seattle, WA in 2002. Since then, Ping worked as a DMPK scientist at Pfizer in La Jolla (2002-2005), a pharmacokineticist at Sonus Pharmaceuticals in Seattle (2005-2007), a clinical pharmacologist at Amgen in Seattle (2008). In June 2008, Ping joined the Office of Clinical Pharmacology at FDA. His primary responsibilities include reviewing IND and NDA applications, assessing the effect of multiple patient factors (intrinsic and extrinsic) using PBPK, and evaluating the application of PBPK tools to support regulatory review and policy development. He contributes the update of several “Guidance for Industry” documents, with a focus on the use of mechanistic modeling approach. Ping manages and mentors several research fellows on multiple regulatory research projects, including Critical Path, Office of Women’s Health, and Medical Counter Measure Initiatives.